ExodusPoint Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$106K	Buy	+15,785	New	+$106K	﹤0.01%	1283
2025 Q1	–	Sell	-16,453	Closed	-$284K	–	1871
2024 Q4	$284K	Buy	16,453 +1,113	+7%	+$19.2K	﹤0.01%	1180
2024 Q3	$245K	Sell	15,340 -184	-1%	-$2.94K	﹤0.01%	1309
2024 Q2	$221K	Buy	+15,524	New	+$221K	﹤0.01%	1251